Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Discovery of Novel 1,2,4-Triazolo-1,2,4-Triazines With Thiomethylpyridine Hinge Binders As Potent C-Met Kinase Inhibitors Publisher Pubmed



Dadashpour S1, 2 ; Kucukkilinc TT3 ; Ayazgok B3 ; Hosseinimehr SJ4 ; Chippindale AM5 ; Foroumadi A6 ; Irannejad H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
  2. 2. Stud. Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  3. 3. Department of Biochemistry, Faculty of Pharmacy, Hacettepe University, Sihhiye, Ankara, 06100, Turkey
  4. 4. Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
  5. 5. Department of Chemistry, University of Reading, Whiteknights, Reading, Berks, RG6 6AD, United Kingdom
  6. 6. Department of Medicinal Chemistry, Faculty of Pharmacy, Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Source: Future Medicinal Chemistry Published:2019


Abstract

Aim: Mesenchymal-epithelial transition factor (c-Met)/HGF overactivation is involved in diverse human cancers. Materials & methods: Herein, we report the synthesis and biological evaluation of thiomethylpyridine-linked triazolotriazines as c-Met kinase inhibitors. Results: Compounds 10b and 11e were more potent than crizotinib on HepG2 cells with IC50 values of 0.74 and 0.71 μM in the MTT assay, respectively. Interestingly, all of the target compounds displayed IC50 values in the range of 3.9-11.1 nM in the c-Met kinase inhibition assay which were lower than the value for crizotinib (11.1 nM). Conclusion: Target compound 10b can be considered as a leading drug candidate due to its lower IC50 values than crizotinib in both HGF-induced proliferation and c-Met kinase inhibition assays. © 2019 Newlands Press.